Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors—a smart fighter that destroys ...

Groundbreaking cancer treatment is taking place at Albany Medical Center.New York Oncology Hematology offering CAR-T therapy, ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

Discover Nkarta's groundbreaking cell therapy advancements, robust financials, and investment potential. Click here to read ...